Navigation Links
Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
Date:11/11/2008

he regimen of patients who were already taking either aspirin or aspirin plus a thienopyridine. Regarding the safety endpoint, a composite of TIMI major bleeding, TIMI minor bleeding and any bleeding requiring medical attention, the researchers found that bleeding incidents increased with increasing doses of rivaroxaban. Bleeding ranged from 6.1 percent of patients receiving 5 milligrams (mg) of the drug each day to 15.3 percent of those receiving 20 mg daily compared to a 3.3 percent rate of bleeding incidents in patients receiving placebo, he said. Overall, 82 percent of all bleeding incidents fell in the mildest, non-TIMI tier of severity, he added.

The study reported no significant risk reduction (p=0.10) for rivaroxaban patients compared to placebo patients for the primary efficacy composite endpoint of all-cause death, heart attack, stroke and severe recurrent chest pain (ischemia) requiring revascularization with bypass surgery or angioplasty. It did report a significant risk reduction for treated vs. placebo patients for the secondary efficacy composite endpoint of death, heart attack or stroke and that finding did reach statistical significance (p=0.028), he said.

The study followed patients being treated for ACS who were first divided into two strata depending on what usual care they received at their home medical center, he explained. Patients receiving aspirin entered Stratum I (706 patients) while those receiving aspirin plus a thienopyridine entered Stratum II (2,731 patients). All patients then had either placebo or one of four total daily doses of the Factor Xa inhibitor on a once- or twice-a-day schedule added to their regimen.

Aspirin and thienopyridines are anti-clotting agents that interfere with platelet aggregation, which is the clumping together of these blood cells. Factor Xa inhibitors interfere with formation of the fine threads of thrombin that bind the platelets together into a blood clot, he said.

Warfarin, th
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
2. Ceregene Phase 2 Clinical Trial for Alzheimers Disease to be Funded by $5.4 Million Grant From National Institutes of Health
3. Derma Sciences Enrolls First Patient in DSC127 Phase II Study
4. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
5. Phase 2a Data for MEDI-528 Presented at CHEST 2008
6. Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study
7. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
8. QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
9. Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
10. Teksouth Awarded $100,000 Defense Department Grant in First Phase of Medical Data Integration Project
11. Assessing the quality of phase I clinical trial abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Calif. (PRWEB) August 29, 2014 LiveOps, ... customer service solutions, today announced that LiveOps has been ... Dystrophy Association's (MDA) Show of Strength Telethon for the ... event raises money and awareness to support MDA’s mission ... an aggressive and sometimes fatal muscle disease. This year’s ...
(Date:8/29/2014)... HealthDay Reporter THURSDAY, ... of American babies are getting the vaccines they need ... said Thursday. More than 90 percent of children ... rubella (MMR); polio; hepatitis B and chickenpox (varicella), according ... "Nationally, vaccination among children 19 to 35 months ...
(Date:8/29/2014)... August 29, 2014 Floors of hospitals ... when wearing socks. Also, many patients are relegated to ... balance, surgery recovery, Alzheimer’s, etc. Two inventors from Perrysburg, ... optimize patient safety. , This special pair of socks ... also keeps patients who are relegated to beds or ...
(Date:8/29/2014)... (HealthDay News) -- Selling cigarettes in plain packages doesn,t ... doesn,t harm sales in small stores, according to new ... the tobacco industry when it tried to prevent Australia ... introduce plain packaging for tobacco products in 2012. Similar ... the U.K. Researchers surveyed nearly 2,000 adult smokers ...
(Date:8/29/2014)... 29, 2014 Honey Gifts, premium Vancouver ... will now be selling purse-sized adult toys and erotic ... that they can be carried in a woman’s purse ... purse-sized range at Honey Gifts is also leak-free and ... and rechargeable batteries are common characteristics of Honey Gifts’ ...
Breaking Medicine News(10 mins):Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2
... COCONUT CREEK, Fla., Aug. 31 e-Telmed, Inc., ( ... and Synergistic Healthcare, a national leader in distributing and designing ... that they have signed an exclusive agreement. This partnership, targeting ... of healthcare in the U.S., it creates a viable solution ...
... , , , NEW ... plate, "O BLOOD," Albert Fischer of Massapequa, NY is a rare breed. ... one out of 200, and a dedicated blood donor. , , ... 2009 will be Albert Fischer,s 320th volunteer whole blood donation, the most ...
... , , ST. LOUIS, Aug. 31 While ... here in Missouri. Don,t fret, the exams we are referring to are ... should take place before or shortly after the start of the new school ... are up-to-date, a dental exam and a vision exam. , , ...
... , , FAIRFAX, Va., Aug. 31 ... in Health and Human Services (HHS) issued key considerations and ... and Reinvestment Act (ARRA), Title XIII funding document. ... is: , , Privacy and security ...
... CLEVELAND, Aug. 31 Two new studies published in ... show that granite used in countertops poses no radon or ... on the results of our research, we did not identify any ... exposures that exceed health-protective limits or background levels commonly found in ...
... PHOENIX, Aug. 31 Noteworthy Medical Systems, ... for the ambulatory sector, announced today its recent participation ... being developed to provide a secure, nationwide, interoperable health ... supporting healthcare. Noteworthy was one of a select few ...
Cached Medicine News:Health News:e-Telmed, Inc., the Leading Telehealth Solution Provider, Signs Exclusive Agreement with Synergistic Healthcare 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 2Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 3Health News:This Guy's Got Blood, and Heart -- At 320 and Counting, Al Fischer Sets Record for Blood Donations 4Health News:Is it Exam Time for School Children Already? 2Health News:Is it Exam Time for School Children Already? 3Health News:Is it Exam Time for School Children Already? 4Health News:Is it Exam Time for School Children Already? 5Health News:Edmond Scientific Company Rallies as Certifications & Assessments (C&A) Provider for HIEs Pursuing ARRA-ONC Grants 2Health News:Independent Analysis Shows Granite Countertops Pose No Health Risk 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 2Health News:Noteworthy Medical Systems Demonstrates National Health Information Network (NHIN) Interoperability 3
(Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire/ –  Royal ... AEX: PHIA) today announced its ... of Cardiology (ESC) Congress 2014 , where ... of its cardiology solutions serving clinicians and patients ... and diagnosis, to treatment, recovery ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Forecast 2014-2024 http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... delivery – discover technological and commercial prospects ... needle-free delivery market? Visiongain,s brand new report ...
Breaking Medicine Technology:DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... Camera from ImagingPlanet Research Microscopy ... delivers increased image resolution and precise ... Document, Archive and Publish with ... microscope camera designed for microscope or ...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The DEI 750 MD from Optronics is a surgical 3 CCD color microscope camera with a 10 meter head cable. Easily mounts on your microscopes C-mount adapter and is the best choice for your surgical imagin...
Medicine Products: